Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Editorial

Whether to anticoagulate: Toward a more reasoned approach

Theodore T. Suh, MD, PhD, MHS
Cleveland Clinic Journal of Medicine January 2017, 84 (1) 41-42; DOI: https://doi.org/10.3949/ccjm.84a.16086
Theodore T. Suh
Associate Professor, Internal Medicine, Geriatric and Palliative Medicine, University of Michigan Health System, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Risk scores discussed in this article

    For predicting stroke risk in atrial fibrillation without anticoagulation therapy
    CHADS2—1 point each for congestive heart failure, hypertension, age ≥ 75, diabetes mellitus; 2 points for prior stroke or transient ischemic attack (possible points 6)2
    CHA2DS2-VASc—1 point each for congestive heart failure, hypertension, age 65–74, diabetes mellitus, vascular disease (coronary artery disease, peripheral arterial disease, aortic aneurysm), sex category female; 2 points for age ≥ 75 and for prior stroke or transient ischemic attack (possible points 9)3
    For predicting bleeding risk with anticoagulation therapy
    ATRIA—anemia, 3 points; severe renal disease, 3 points; age ≥ 75, 2 points; previous bleeding event, 1 point; hypertension 1 point (possible points 10); ATRIA stands for Anticoagulation and Risk Factors in Atrial Fibrillation study4
    HAS-BLED—1 point each for hypertension, abnormal renal function, abnormal liver function, stroke, bleeding history, labile international normalized ratio, elderly status (age > 65), drugs, and alcohol abuse (possible points 9)5,6
    HEMORR2HAGES—1 point each for hepatic or renal abnormality, ethanol abuse, malignancy, older age (> 75) reduced platelet function; 2 points for rebleeding risk; and 1 point each for hypertension (uncontrolled) anemia, genetic factors, excessive falls, and stroke (possible points 12)7
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 84 (1)
Cleveland Clinic Journal of Medicine
Vol. 84, Issue 1
1 Jan 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Whether to anticoagulate: Toward a more reasoned approach
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Whether to anticoagulate: Toward a more reasoned approach
Theodore T. Suh
Cleveland Clinic Journal of Medicine Jan 2017, 84 (1) 41-42; DOI: 10.3949/ccjm.84a.16086

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Whether to anticoagulate: Toward a more reasoned approach
Theodore T. Suh
Cleveland Clinic Journal of Medicine Jan 2017, 84 (1) 41-42; DOI: 10.3949/ccjm.84a.16086
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • BETTER RISK PREDICTORS ARE NEEDED
    • THE PATIENT’S PREFERENCES MATTER
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Fall risk and anticoagulation for atrial fibrillation in the elderly: A delicate balance
  • PubMed
  • Google Scholar

Cited By...

  • In reply: Anticoagulation for atrial fibrillation (January 2017)
  • Anticoagulation for atrial fibrillation (January 2017)
  • Google Scholar

More in this TOC Section

  • The beat goes on: Highlights from the new American and European A-fib guidelines
  • Subclinical hypothyroidism: What’s in a name?
  • Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
Show more Editorial

Similar Articles

Subjects

  • Cardiology
  • Drug Therapy
  • Geriatrics
  • Neurology
  • Vascular Medicine

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire